BIO 2018: Former judge weighs in on differing patent standards

Why has the US Supreme Court never granted certiorari on the issue of differing standards required to prove patent invalidity at district courts and at the US Patent and Trademark Office (USPTO)?

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

BIO 2018: Allergan-tribe deal just the start, says former USPTO director

8 June 2018 “The Saint Regis Mohawk Tribe issue is not unique to just life sciences—we’re likely to see it across the board. There’s likely been other transfers that are not yet public information,” said Teresa Rea, vice-chair of Crowell & Moring’s IP group and former director of the US Patent and Trademark Office.

Americas

BIO 2018: Kraft president talks biotech and sport

7 June 2018 Private capital must finance the life sciences industry in the US otherwise the country will lose its advantage in the life sciences field, claimed Jonathan Kraft, president of The Kraft Group.

Americas

BIO 2018: TV presenter Robin Roberts relives cancer battle

6 June 2018 In 2007, Robin Roberts, co-anchor for ABC News’s Good Morning America show, was diagnosed with breast cancer. Five years later, she was diagnosed with myelodysplastic syndrome, a disease of the blood and bone marrow once known as pre-leukaemia.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

BIO 2018: Former judge weighs in on differing patent standards

More on this story

Editor's picks

Editor's picks

More features